Unum Group (NYSE:UNM) Shares Sold by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC lowered its position in shares of Unum Group (NYSE:UNM) by 91.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,974 shares of the financial services provider’s stock after selling 50,751 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Unum Group were worth $363,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. boosted its position in shares of Unum Group by 1.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,500,508 shares of the financial services provider’s stock valued at $326,950,000 after purchasing an additional 55,014 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Unum Group by 50.0% during the third quarter. Franklin Resources Inc. now owns 469,342 shares of the financial services provider’s stock worth $29,554,000 after buying an additional 156,380 shares in the last quarter. Blue Trust Inc. grew its position in Unum Group by 44.1% in the fourth quarter. Blue Trust Inc. now owns 16,495 shares of the financial services provider’s stock worth $1,205,000 after buying an additional 5,047 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of Unum Group by 89.5% in the third quarter. Thrivent Financial for Lutherans now owns 111,831 shares of the financial services provider’s stock valued at $6,647,000 after buying an additional 52,813 shares in the last quarter. Finally, Kovitz Investment Group Partners LLC acquired a new stake in shares of Unum Group during the 3rd quarter valued at $1,074,000. 86.57% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Lisa G. Iglesias sold 5,000 shares of Unum Group stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $72.61, for a total value of $363,050.00. Following the transaction, the executive vice president now owns 35,840 shares of the company’s stock, valued at $2,602,342.40. This trade represents a 12.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the company’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $76.92, for a total transaction of $769,200.00. Following the sale, the executive vice president now directly owns 54,827 shares of the company’s stock, valued at approximately $4,217,292.84. This represents a 15.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 83,865 shares of company stock worth $6,315,082. Corporate insiders own 0.93% of the company’s stock.

Unum Group Stock Performance

Shares of UNM stock opened at $75.44 on Friday. Unum Group has a fifty-two week low of $48.11 and a fifty-two week high of $79.43. The stock’s 50-day moving average is $74.21 and its two-hundred day moving average is $65.87. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.29 and a quick ratio of 0.28. The firm has a market cap of $13.78 billion, a P/E ratio of 7.97, a PEG ratio of 1.17 and a beta of 0.80.

Unum Group (NYSE:UNM) last released its quarterly earnings data on Tuesday, February 4th. The financial services provider reported $2.03 EPS for the quarter, missing analysts’ consensus estimates of $2.14 by ($0.11). Unum Group had a return on equity of 14.91% and a net margin of 13.81%. Analysts predict that Unum Group will post 9.12 earnings per share for the current fiscal year.

Unum Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Friday, January 24th will be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend is Friday, January 24th. Unum Group’s dividend payout ratio is presently 17.74%.

Analyst Ratings Changes

UNM has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods boosted their target price on Unum Group from $88.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday. Evercore ISI upgraded Unum Group from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $67.00 to $84.00 in a report on Thursday, November 14th. BMO Capital Markets assumed coverage on shares of Unum Group in a report on Thursday, January 23rd. They issued an “outperform” rating and a $91.00 target price for the company. Barclays boosted their price target on shares of Unum Group from $76.00 to $85.00 and gave the company an “overweight” rating in a report on Monday, January 6th. Finally, Morgan Stanley upped their price target on shares of Unum Group from $62.00 to $64.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.33.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.